COST-EFFECTIVENESS ANALYSIS OF A RANDOMIZED TRIAL OF AN MHEALTH INTERVENTION TO IMPROVE CARDIOMETABOLIC PROFILE IN PREHYPERTENSIVE SUBJECTS FROM LOW-RESOURCE URBAN SETTINGS IN LATIN AMERICA
Author(s)
Augustovski F1, Palacios A1, Beratarrechea A1, Diez-Canseco F2, Irazola V1, Ramirez-Zea M3, Pichon-Riviere A1, Rubinstein A1
1Institute for Clinical Effectiveness and Health Policy (IECS), Buenos Aires, Argentina, 2CRONICAS Center of Excellence in Chronic Diseases, Universidad Peruana Cayetano Heredia, Lima, Peru, 3INCAP Research Center for the Prevention of Chronic Diseases (CIIPEC), Institute of Nutrition of Central America and Panama, Guatemala, Guatemala
OBJECTIVES:: The parent randomized controlled trial evaluated a mobile health (mHealth) intervention to improve healthy lifestyles and cardiometabolic profile in pre-hypertensive subjects from low-resource settings in Argentina, Guatemala and Peru. It showed no reductions in its primary outcome -blood pressure- but a significant reduction in body weight. Additionally, health related quality of life was not reported in the primary trial report. We report the cost-effectiveness analysis alongside this trial. METHODS:: Health outcomes were Quality Adjusted Life Years (QALYs) derived with EQ-5D-3L, weight (in Kg) and costs (reported in 2015 International dollars [I$]). We evaluated mean net changes between groups from baseline to 12 months of follow-up. A healthcare sector perspective for costs was used Incremental Cost-Effectiveness Ratios (ICER) and their uncertainty were estimated. RESULTS::
Conference/Value in Health Info
2017-09, ISPOR Latin America 2017, Sao Paulo, Brazil
Value in Health, Vol. 20, No. 9 (October 2017)
Code
PCV11
Topic
Economic Evaluation
Topic Subcategory
Cost-comparison, Effectiveness, Utility, Benefit Analysis
Disease
Cardiovascular Disorders
Your browser is out-of-date
ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now